Global Sore Throat Remedies Market Size By Type (Lozenges, Oral Syrup), By Application (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2023 to 2032

The Global Sore Throat Remedies Market was valued at USD 5.6 billion in 2023 and is projected to reach USD 8.9 billion by 2031, growing at a CAGR of 6.1% during the forecast period from 2023 to 2031. The market is expanding due to rising incidences of viral and bacterial infections, increased awareness of over-the-counter (OTC) medications, and the growing adoption of natural and herbal sore throat treatments. Additionally, seasonal changes, environmental pollution, and smoking habits are further contributing to the high prevalence of sore throat cases globally, boosting the demand for effective remedies.

Drivers:

1. Rising Incidence of Respiratory Infections:

The prevalence of upper respiratory tract infections, including colds, flu, and strep throat, is a significant driver. Seasonal outbreaks, such as influenza, contribute to a higher demand for sore throat remedies across age groups.

2. Growth in OTC Pharmaceutical Sales:

OTC products offer convenience, cost-effectiveness, and rapid relief, making them a preferred choice among consumers. This trend supports robust growth for lozenges, sprays, and syrups targeted at sore throat relief.

3. Increasing Preference for Herbal and Natural Products:

Consumers are gravitating toward remedies with natural ingredients like honey, eucalyptus, and licorice, driven by growing health awareness and concerns about synthetic chemicals.

Restraints:

1. Side Effects of Chemical-Based Products:

Synthetic sore throat treatments can lead to side effects such as drowsiness or allergic reactions, discouraging some consumers from using conventional products.

2. Availability of Alternative Remedies:

Home-based and traditional remedies, such as saltwater gargles and warm fluids, are easily accessible and cost-free, which may limit the market penetration of commercial products.

Opportunity:

1. Expansion in Emerging Economies:

Emerging markets in Asia-Pacific and Latin America are witnessing growing healthcare awareness and increasing spending on personal health products, presenting lucrative growth opportunities.

2. Product Innovation and Formulation Development:

Ongoing R&D in drug delivery mechanisms, such as fast-dissolving lozenges and throat sprays with enhanced efficacy, offer avenues for product differentiation and market expansion.

Market by System Type Insights:

Based on system type, the Lozenges segment held the largest share of the market in 2023. Lozenges are preferred due to their ease of use, quick relief effect, and availability in various flavors. The Sprays segment is expected to exhibit the fastest growth during the forecast period, attributed to innovations in rapid-action formulas and increased consumer demand for instant throat soothing effects.

Market by End-use Insights:

The Retail Pharmacy segment emerged as the largest distribution channel in 2023, benefiting from widespread availability and consumer trust. The Online Pharmacy segment is growing rapidly due to convenience, rising smartphone penetration, and increased reliance on e-commerce platforms post-pandemic.

Market by Regional Insights:

North America led the global sore throat remedies market in 2023, owing to high healthcare spending, well-established retail networks, and a proactive approach to minor ailment management. Asia-Pacific is anticipated to record the fastest CAGR through 2031 due to increasing healthcare access, rising disposable income, and growing awareness about preventive care.

Competitive Scenario:

Prominent players in the Global Sore Throat Remedies Market include:

Reckitt Benckiser Group plc (Strepsils)

GlaxoSmithKline plc (Cepacol)

Procter & Gamble Co. (Vicks)

Johnson & Johnson (Tylenol)

Pfizer Inc. (Theraflu)

Novartis AG

Sanofi S.A.

Prestige Consumer Healthcare Inc.

Himalaya Global Holdings Ltd.

Emami Limited

These companies focus on launching new product formats, expanding into natural remedy lines, and leveraging digital platforms for wider market reach. For instance:

In 2024, Reckitt launched an herbal variant of Strepsils targeting health-conscious consumers.

In 2023, GSK introduced a dual-action sore throat spray in the U.S. with antibacterial and pain relief properties.

Scope of Work – Global Sore Throat Remedies Market

Key Market Developments:

May 2023 – Johnson & Johnson expanded its Tylenol product line with a sore throat formula infused with honey and lemon for enhanced palatability.

October 2023 – Sanofi launched a multi-symptom syrup in Europe, combining throat relief with cough suppressant properties.

January 2024 – Himalaya introduced a sugar-free lozenge targeted at diabetic consumers across Asia.

FAQs:

1) What is the current market size of the Global Sore Throat Remedies Market?

The market was valued at USD 5.6 billion in 2023.

2) What is the major growth driver of the Global Sore Throat Remedies Market?

The market is primarily driven by rising incidences of respiratory infections and increasing consumer preference for OTC and natural remedies.

3) Which is the largest region during the forecast period in the Global Sore Throat Remedies Market?

North America accounted for the largest share in 2023, but Asia-Pacific is expected to register the fastest growth through 2031.

4) Which segment accounted for the largest market share in Global Sore Throat Remedies Market?

The Lozenges segment accounted for the largest share by system type in 2023.

5) Who are the key market players in the Global Sore Throat Remedies Market?

Leading companies include Reckitt Benckiser, GSK, Procter & Gamble, Johnson & Johnson, and Pfizer among others.